Cost-Containment: The Best Medicine
Mr. Speaker, this Member wishes to commend AARP CEO Bill Novelli for sending a letter Monday to the heads of the leading pharmaceutical companies, requesting their cooperation in holding down drug price increases. While this Member has…
Mr. Speaker, this Member wishes to commend AARP CEO Bill Novelli for sending a letter Monday to the heads of the leading pharmaceutical companies, requesting their cooperation in holding down drug price increases.
While this Member has questions about limiting drug price increases to an amount no greater than the level of inflation as advocated in this letter, this Member generally supports several of the concepts mentioned by Mr. Novelli, including prescription drug reimportation and drug efficacy studies.
Clearly, millions of Americans are finding prescription drug reimportation from Canada and other countries to be a viable and necessary alternative to high-priced drugs in the United States. The number of those Americans is growing every day. It would be wrong for Members of Congress to ignore this reality and to ignore the excessive cost of prescription drugs in America.
Large pharmaceutical manufacturers have long been gouging American consumers by charging substantially more, in some cases up to 90 percent more, for prescription drugs sold in the United States than in Canada and other industrialized countries. Increasing numbers of Americans understandably refuse to be exploited by the pharmaceutical industry any longer. The exploitation of American consumers must end. The excuse that most of the world's pharmaceutical research and development takes place in America does not justify the continued degree of cost-shifting onto the backs of American consumers. Profit levels of American, foreign, and multi-national pharmaceutical firms are among the highest in the business world, as is the level of their advertising budgets and inducements offered to prescribing physicians.
The reimportation debate is not a battle of right versus left. It is a battle of right versus wrong. It is simply wrong to require Americans to pay the world's highest prices for prescription drugs, so they thereby can subsidize consumers everywhere else on earth to generate the research, advertising and profit revenues for pharmaceutical companies.
As a Member of Congress serving in the people's House, this Member has a responsibility to do what is right for Nebraskans and all Americans. This Member supports prescription drug reimporation because Americans deserve access to quality drugs at world market prices and reimportation seems to be the only solution immediately available to reduce the gross overcharge of American consumers for prescription drugs.
This Member is also supportive of drug efficacy studies. This Member offered an amendment to the House Labor, Health and Human Services, and Education appropriations bill, requiring the Agency for Healthcare Research and Quality (AHRQ to spend $12 million to conduct research on the clinical appropriateness and cost-effectiveness of prescription drugs. This language was maintained and included in the final appropriations measure, which was signed into law.
Americans deserve the best health care for their dollar. It is essential for clinicians, patients, health plans, insurers, and those financing health care services to have access to credible, objective information on the benefits, risks, and costs of prescription drugs so they can make informed decisions about the prescriptions they consume and prescribe. Americans need information regarding the effectiveness, quality, and cost-effectiveness of new drugs, in comparison with existing alternatives, especially when new drugs can cost much more than those now on the market. Understanding which medicines work the best for which patients and at what costs, as well as understanding how to administer and monitor medication use in a way that ensures patients' safety is of critical importance to the health care system.
Mr. Speaker, in closing, this Member encourages measures to control the outrageous costs of lifesaving prescription drugs. This is the best medicine for Nebraskans and all Americans.